Status:
COMPLETED
A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators are conducting a project to provide a new type of resource called "hand lettering" to patients receiving chemotherapy. This is a type of art therapy. The goal of this project is to u...
Detailed Description
This study is being done to understand if it is feasible to use a form of art-therapy called hand-lettering at Dana-Farber Cancer Institute. We would also like to explore the anxiety a person has befo...
Eligibility Criteria
Inclusion
- Adult patients (\>age 18) with a cancer diagnosis receiving oral or IV chemotherapy at Dana-Farber on Yawkey 10.
- Able to read and speak English
- Has a minimum appointment time of 60 minutes
Exclusion
- Individuals with visual impairment or blindness will be excluded
Key Trial Info
Start Date :
January 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2018
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03291730
Start Date
January 9 2018
End Date
June 5 2018
Last Update
December 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115